Li et al. [88] have used the knowledge of the inhibition of PP1 and PP2A by cantharidin, and the resulting apoptosis of cancer cells, to design a new gene therapy approach to kill hepatocellular carcinoma cells. This evidence concerns the gene PTPA and cancer.